Levin Simes Kaiser and Gornick, LLP

VYTORIN CLASS ACTION
On January 14, 2008, Merck & Co., Inc. and the Shering-Plough Corporation released the long awaited ENHANCE study assessing the effectiveness of Vytorin...

GADOLINIUM
Gadolinium is a chemical element used in image contrast agents during magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) procedures.

TRASYLOL SIDE EFFECTS
Trasylol, also known as aprotinin, received approval by the U.S. Food and Drug Administration in 1993 for the purpose of reducing bleeding in patients undergoing cardiopulmonary bypass during a coronary artery bypass graft...

MALIGNANT MESOTHELIOMA
Malignant mesothelioma is a fatal cancer affecting the mesothelial tissue of the heart, lungs and/or abdomen

MEDTRONIC RECALL
Medtronic, a leading manufacturer of medical devices, has voluntarily recalled several pacemaker and implantable defibrillator models due to serious defects...

GUIDANT RECALL
In June 2005, Guidant voluntarily recalled its implantable defibrillators due to the risk the device could experience an internal short circuit. This defect could prevent the defibrillator from delivering the shock required...

BEXTRA
Bextra is a non-steroidal anti-inflammatory prescription medication used to control tissue inflammation related to osteoarthritis and rheumatoid arthritis. It is part of a drug group known as COX 2 inhibitors, which includes major brand names such as Celebrex and Vioxx. Pfizer, the manufacturer of Bextra, voluntarily recalled the drug on April 17, 2005.

VIOXX RECALL
On September 30, 2004, Vioxx’s manufacturer, Merck & Co., Inc. voluntarily removed the drug from the market after a study showed the drug increased a patient’s risk of dangerous cardiovascular problems, including heart attacks and strokes.

$10.3 million verdict on behalf of a 60 year-old man suffering from mesothelioma

$6.5 million verdict on behalf of a 59 year-old mesothelioma victim

$2.5 million verdict on behalf of a 73 year-old mesothelioma victim

Settlement reached after jury selection on behalf of a 57 year-old terminal cancer victim who had been exposed to asbestos in the Navy, as an auto mechanic and as a plant maintenance worker

Levin Simes Kaiser & Gornick, LLP is a nationally recognized firm representing seriously injured individuals throughout the United States. LSK&G has represented thousands of individuals in products liability cases and tens of thousands of people in consumer protection class actions.

Fill out the form below and a representative from our office will get back to you as soon as possible.

Levin Simes Kaiser & Gornick, LLP
44 Montgomery Street, 36th floor
San Francisco, CA 94104

Ph: 1.800.901.4001
Fax: 415.981.1270

DISCLAIMER
While we attempt to keep the information on our website accurate, we cannot guarantee that it is entirely correct or complete. Our website complies and is intended to comply with the laws and regulations of the State of California.Levin Simes Kaiser & Gornick, LLP cannot guarantee the outcome of any particular case.Users of our website, including those who send us electronic mail, do not enter into any type of attorney-client relationship with Levin Simes Kaiser & Gornick, LLP unless separately and expressly confirmed by Levin Simes Kaiser & Gornick, LLP.

PRIVACY STATEMENT
We do not gather any information about you from this website aside from what you might choose to send us in an email. Your information is not shared with anyone except with your express permission. When you contact Levin Simes Kaiser & Gornick, LLP by e-mail or any other medium and give us information about yourself, including your e-mail address, we will hold it in confidence, whether or not you retain us as legal counsel. If you supply us with your postal or e-mail address, or your telephone number, you will only receive the information or telephone contact that you requested at the time that you provided us with this information. Upon written request we will provide site visitors with access to e-mails that the visitor has directed to our site. Visitors can obtain this information by writing to us. We cannot give access to any other information about individual visitors because we do not possess such information. If our practices change at some time in the future we will state this change and use only data collected from the time of the policy change forward.